Alvin L.

Over 30+ years' experience in global drug development (from bench to the beside) through successful commercial launch in boutique / mid-sized, and large public or private biotechnology to the biopharmaceutical organizations. Skilled in orphan drugs, rare diseases, therapeutic areas (such as hematology, CNS, ophthalmology, immuno-oncology), AAV-mediated gene therapy, go-to-market strategy and regulatory negotiation. Proven track record of more than 250 cumulative total of regulatory submissions in the USA, CAN, EU, ARG, IBSA (India, Brazil and South Africa), and APAC, leading to the participation in the development of 21 approved products from clinical development to marketing approval and launch. Strong business development professional holds degrees from Harvard Business School and University of California San Francisco School of Medicine and certifies for clinical research.